Extreme Hair Fall: Causes & Treatments

Step 1 - Identify the Type (This Drives Treatment)

Step 2 - First-Line Medical Treatments

1. Minoxidil (Rogaine) - Cornerstone therapy for both men & women

• Topical 5% (men) or 2% (women) applied daily to scalp
• Low-dose oral minoxidil (0.25 - 2.5 mg/day) is now widely used and effective, especially for women or those who cannot tolerate topical formulation
• Works by prolonging the anagen (growth) phase and widening hair follicles
• Important: Expect initial "dread shed" - increased shedding around week 4 that actually predicts good response. Improvement seen at 3-6 months minimum
• Stopping minoxidil causes acute telogen efflux 3-4 months later - it must be continued long-term to maintain results
• Source: Goldman-Cecil Medicine, p. 4334

2. Finasteride / Dutasteride (for men, and select women)

• Finasteride 1 mg/day (oral) - FDA-approved for male pattern hair loss; blocks DHT conversion, which drives follicle miniaturization
• Topical finasteride spray is equally effective to oral with less systemic DHT suppression - important for minimizing sexual side effects
• Dutasteride 0.5 mg/day (approved in some countries) - more potent than finasteride, similar safety profile
• A 2025 network meta-analysis (PMID 40586152) directly compared minoxidil vs. 5-alpha reductase inhibitors and found finasteride/dutasteride superior for hair count improvement in male AGA
• Side effects to know: A small percentage experience post-finasteride syndrome (persistent sexual dysfunction, depression); pregnant women must never handle these tablets
• Source: Goldman-Cecil Medicine; Cummings Otolaryngology

3. Treatment Timeline

• Must continue for at least 6 months before judging efficacy
• Cessation of finasteride leads to gradual return to baseline within 1 year
• Combination of minoxidil + finasteride is more effective than either alone

Step 3 - Treating Alopecia Areata (Autoimmune Hair Loss)

• Intralesional corticosteroids - first-line for localized patches and eyebrows
• High-potency topical steroids (under occlusion) for acute/severe disease
• Topical immunotherapy - diphenylcyclopropenone (DCPCP) or squaric acid (SADBE) for chronic cases
• JAK inhibitors - most exciting recent advance:
  • Baricitinib (2-4 mg/day) - FDA-approved for severe alopecia areata
  • Ruxolitinib (10-20 mg twice daily)
  • Tofacitinib (5-10 mg twice daily)
  • Ritlecitinib - also under review for approval
  • These have shown highly effective hair regrowth in severe cases, but relapses are common if stopped
• Source: Goldman-Cecil Medicine, p. 4334-4335

Step 4 - Treating Telogen Effluvium (Diffuse Shedding After a Trigger)

• This type is largely self-limiting - hair usually recovers within 6-9 months once the trigger resolves
• No specific pharmaceutical treatment is required in most cases
• Address root causes: correct iron deficiency (ferritin < 40 ng/mL), fix protein/vitamin D/zinc deficiencies, manage thyroid disease
• A 2024 systematic review (PMID 39440586) confirmed micronutrients (iron, zinc, vitamin D, biotin) play a role in androgenetic alopecia and diffuse hair loss

Step 5 - Other Proven Treatments

Platelet-Rich Plasma (PRP)

• Injections of your own concentrated platelets into the scalp
• Stimulates follicle growth factors (VEGF, PDGF)
• Evidence is moderate but growing; a 2024 systematic review (PMID 39630665) examined PRP's role in both androgenetic and scarring alopecias
• Works best as adjunct to minoxidil/finasteride

Hair Transplant Surgery

• Best for severe androgenetic alopecia where medical therapy is insufficient
• Two main techniques: FUE (Follicular Unit Extraction) and FUT (strip method)
• Finasteride 1 mg/day improves long-term outcomes after transplant
• Hair transplant in women is more difficult due to diffuse thinning in donor areas

Ketoconazole Shampoo (2%)

• Anti-fungal with anti-DHT properties; used 2-3x/week
• Modest benefit as adjunct; OTC in many countries

Microneedling (Dermaroller)

• Creates microchannels that enhance minoxidil absorption and stimulate growth factors
• Used alongside topical minoxidil for enhanced results

Step 6 - Emerging (2025-2026) Options

• Topical dutasteride - more potent DHT blockade than finasteride; prescription only
• PP405 (Pelage Pharmaceuticals) - targets follicle stem cell dormancy; Phase II showed 31% of men had >20% hair density gain; Phase III starting 2026 per Healthline reporting
• Exosome therapy - cell-free regenerative injections; early data shows improvements in density/thickness, but clinical evidence is still heterogeneous

Key Practical Tips

1. See a dermatologist for a proper diagnosis before self-treating - especially for patchy loss, scalp inflammation, or loss at the margins
2. Blood tests to request: CBC, ferritin, TSH, vitamin D, zinc, DHEAS (women), DHT
3. Combination therapy almost always outperforms monotherapy
4. Consistency is the single biggest factor - most people fail by stopping too early